Immunome (IMNM) earnings, Aug 11, 2026: EPS −30%, stock +6.6%
In brief
Immunome reported on Aug 11, 2026. Earnings per share changed −30% year over year, 26.5% below the estimate; revenue −100%. The stock opened with a −3.9% gap and closed the day +6.6% (Aug 12, 2026). The stock is now 40.4% below its 52-week high, +16.6% over 12 months. Next report: Nov 16, 2026.
EPS vs estimate−26.5%
EPS, YoY−30%
Revenue, YoY−100%
Gap · day−3.9% · +6.6%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 12, 2026 | +3.1% | −2.2% |
| Aug 11, 2026 | −3.9% | +6.6% |
Next-quarter estimates, ratings and the IMNM chart are in the terminal.
Open the terminalFAQ
When is Immunome's next earnings report?
Nov 16, 2026. The date comes from daily data and is corrected if the company moves it.
How did Immunome stock react to the report?
Opening gap −3.9%, day's result +6.6%.
Did Immunome's earnings grow?
Earnings per share fell 30% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.